Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.990
-0.140 (-4.47%)
At close: Mar 24, 2026, 4:00 PM EDT
3.120
+0.130 (4.35%)
After-hours: Mar 24, 2026, 5:44 PM EDT

Xenetic Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
7.886.178.9813.118.24
Cash & Short-Term Investments
7.886.178.9813.118.24
Cash Growth
27.87%-31.36%-31.41%-28.21%58.27%
Other Current Assets
0.170.420.60.560.48
Total Current Assets
8.056.599.5913.6518.72
Other Long-Term Assets
0.310.311.021.071.09
Total Assets
8.366.910.6114.7219.82
Accounts Payable
0.260.280.240.290.36
Accrued Expenses
0.710.610.570.791.06
Total Current Liabilities
0.970.890.811.071.42
Total Liabilities
0.970.890.811.071.42
Preferred Stock
00000
Common Stock
00000.01
Treasury Stock
-5.28-5.28-5.28-5.28-5.28
Additional Paid-in Capital
212.29208.23208.05207.77205.95
Accumulated Other Comprehensive Income
0.250.250.250.250.25
Retained Earnings
-199.88-197.19-193.23-189.1-182.55
Shareholders' Equity
7.46.019.813.6518.39
Total Liabilities & Equity
8.366.910.6114.7219.82
Net Cash (Debt)
7.886.178.9813.118.24
Net Cash Growth
27.87%-31.36%-31.41%-28.21%58.27%
Net Cash Per Share
4.634.005.889.2117.75
Book Value
7.46.019.813.6518.39
Book Value Per Share
4.353.906.419.5917.89
Tangible Book Value
7.46.019.813.6518.39
Tangible Book Value Per Share
4.353.906.419.5917.89
Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q